Cell Culture Media Market Report 2026

Cell Culture Media Market Overview

• Cell Culture Media market size has reached to $6.13 billion in 2025 • Expected to grow to $10.41 billion in 2030 at a compound annual growth rate (CAGR) of 10.8% • Growth Driver: Rising Pharmaceutical Drug Manufacturing Fuels Growth In The Cell Culture Media Market • Market Trend: Advancements In Cell Culture Media For Enhanced Biopharmaceutical Manufacturing • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Cell Culture Media Market?

Cell culture media refer to nutrient-rich solutions designed to support the growth, maintenance, and proliferation of cells outside of their natural environment. They typically contain a balanced mixture of amino acids, vitamins, minerals, sugars, and growth factors tailored to specific cell types. Media composition can vary widely depending on the cell's requirements and experimental objectives. The main types of cell culture media are liquid media, semi-solid media, and solid media. Liquid media refers to any fluid-based substance or solution used in manufacturing, research, or other operational activities. The different products of cell culture media are serum-free media, classical media, stem cell culture media, specialty media, chemically defined media, and others, which are used in several applications including biopharmaceutical production, diagnostics, drug screening and development, tissue engineering, and regenerative medicine, among others. It is used by various end users, such as the biotechnology and pharmaceutical industries, academic institutes, research laboratories, and others.

What Is The Cell Culture Media Market Growth Forecast?

The cell culture media market size is expected to see rapid growth in the next few years. It will grow to $10.41 billion in 2030 at a compound annual growth rate (CAGR) of 10.8%. The growth in the forecast period can be attributed to advancements in precision medicine, increasing adoption of automated liquid handling systems, growth in tissue engineering and regenerative medicine applications, demand for serum-free and chemically defined media, expansion of cell-based diagnostics and therapies. Major trends in the forecast period include personalized cell culture media formulations, expansion of stem cell research applications, development of serum-free and chemically defined media, automation and high-throughput screening integration, growth in tissue engineering and regenerative medicine.

What Is The Driver Of The Cell Culture Media Market?

The increase in the manufacturing of pharmaceutical drugs is expected to propel the cell culture media market going forward. Pharmaceutical drugs refer to medications or substances used for the prevention, treatment, or diagnosis of medical conditions in humans or animals. The surge in pharmaceutical drug manufacturing can be attributed to the increased prevalence of chronic and infectious diseases and the growing aging population, which necessitates a higher demand for medications to manage age-related conditions and ailments. Cell culture media provide the essential nutrients and environment for the growth and maintenance of cells used in pharmaceutical drug manufacturing, ensuring optimal cell growth and the production of desired therapeutic proteins or molecules. For instance, in December 2024, according to the Association of the British Pharmaceutical Industry (ABPI), a UK-based organization, reported that the total number of clinical trials for drugs initiated in the UK rose from 411 in 2022 to 426 in 2023. Therefore, the increase in the manufacturing of pharmaceutical drugs is driving the growth of the cell culture media industry.

Key Players In The Global Cell Culture Media Market

Major companies operating in the cell culture media market are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Becton Dickinson and Company, Corning Incorporated, Lonza Group AG, Sartorius AG, CYTIVA Lifesciences, Bio-Rad Laboratories Inc., STEMCELL Technologies Inc., Miltenyi Biotec, Takara Bio, MP Biomedicals, FUJIFILM Irvine Scientific Inc., Promocell Inc., InSphero AG, PeproTech Inc., HiMedia Laboratories Pvt. Ltd., Elabscience Biotechnology Inc., Capricorn Scientific GmbH, CAISSON Laboratories Inc., Cell Biologics Inc., Nucleus Biologics LLC

Global Cell Culture Media Market Trends and Insights

Major companies operating in the cell culture media market are focusing on developing innovative culture cell media, such as chemically defined and animal-component-free formulations, to gain a competitive edge in the market. Chemically defined and animal-component-free formulations aim to optimize cell growth and protein production, ultimately improving the scalability and efficiency of biopharmaceutical manufacturing processes. For instance, in July 2023, Lonza Group Ltd., a Switzerland-based healthcare company, launched TheraPRO CHO Media System, an innovative cell culture platform designed to enhance productivity and quality in therapeutic protein manufacture. This new system is tailored to optimize therapeutic monoclonal antibody production and features a chemically defined, animal-component-free, two-part production process, simplifying media preparation and ensuring scalability.

What Are Latest Mergers And Acquisitions In The Cell Culture Media Market?

In March 2025, NETRI, a France-based biotechnology research company, acquired HCS PHARMA for an undisclosed amount. This acquisition of HCS PHARMA assets strengthens its neuro organs-on-chip platforms by integrating patented hydrogels and liver organoid technologies, enabling fully innervated and vascularized 3D human cell cultures. This supports applications in oncology, toxicology, and drug metabolism studies, improving side-effect and pain assessments. Coupled with a new 1,500 m² production facility, the acquisition accelerates NETRI’s ability to offer advanced, integrated solutions for pharmaceutical research and drug development. HCS PHARMA is a France-based biotechnology research company that specializes in providing 3D cell culture technology.

What Defines the Cell Culture Media Market?

The cell culture media market consists of sales of co-culture media, conditioned media, and serum substitute media. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Cell Culture Media Market Report 2026?

The cell culture media market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the cell culture media industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.